On Wednesday, 6th March, the Mater Hospital hosted a commemorative event marking the 200th HIPEC (Heated Intra-Peritoneal Chemotherapy) procedure given to cancer patients in Ireland. Alongside this, was the roll out of this significant service to women with advanced stage ovarian cancer.
Invited by Ireland East Hospital Group, international speakers included Professor Brendan Moran from the UK and Professor Willemien Van Driel from the National Cancer Institute.
Over 200 Cytoreductive Surgery (CRS) combined with HIPEC procedures have been carried out at the Mater Hospital since repatriation from the UK in 2013. This milestone marks a significant development in healthcare, and going forward, it will have an incredible impact on women’s cancer treatment.
Since September 2018, ten women with ovarian cancer have receive the treatment. The Mater Foundation is very proud to support this significant advance in healthcare, and going forward, we aspire to continue to support the Mater Hospital in bringing world class treatment to public patients.